Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Aug 31, 2025 | (Q4)Aug 31, 2025 | (Q3)May 31, 2025 | (Q2)Feb 28, 2025 | (Q1)Nov 30, 2024 | (FY)Aug 31, 2024 | (Q4)Aug 31, 2024 | (Q3)May 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2.30%37.08M | -8.26%9.08M | 0.67%9.13M | 12.73%9.27M | 6.01%9.61M | 11.36%36.25M | 20.66%9.89M | 7.43%9.07M | -0.28%8.22M | 17.98%9.07M |
| Cost of revenue | 9.27%19.41M | 6.24%4.97M | 10.52%4.81M | 14.51%4.93M | 9.36%4.82M | 3.37%17.76M | 9.32%4.68M | 2.16%4.35M | -5.66%4.3M | 5.20%4.41M |
| Gross profit | -4.39%17.68M | -21.28%4.1M | -8.42%4.32M | 10.78%4.35M | 2.83%4.79M | 20.31%18.49M | 33.06%5.21M | 12.81%4.71M | 6.37%3.92M | 33.31%4.66M |
| Operating expense | -13.28%7.63M | -22.44%2.08M | -15.45%1.66M | -5.71%2.01M | -10.34%1.72M | 13.64%8.8M | 42.49%2.68M | 14.49%1.97M | -3.48%2.14M | -5.11%1.91M |
| Selling and administrative expenses | -12.09%8.21M | -12.23%2.22M | -5.47%2.01M | -6.74%2.22M | -10.98%1.96M | 4.63%9.34M | 11.13%2.53M | 3.36%2.12M | -2.70%2.38M | 0.59%2.21M |
| -Selling and marketing expense | -30.72%843.75K | -45.92%212K | -19.76%199K | -2.54%192K | -44.32%201K | -24.39%1.22M | 74.22%392K | 8.30%248K | -5.74%197K | 21.14%361K |
| -General and administrative expense | -9.30%7.37M | -6.04%2.01M | -3.58%1.81M | -7.12%2.02M | -4.45%1.76M | 11.02%8.12M | 4.20%2.13M | 2.74%1.87M | -2.42%2.18M | -2.64%1.84M |
| Other operating expenses | -1.76%180.34K | -75.27%45K | ---- | ---- | ---- | 9,486.11%183.57K | 18,100.00%182K | ---- | ---- | -40.00%3K |
| Total other operating income | 5.05%758.18K | 624.00%181K | 122.88%341K | -15.90%201K | -15.99%247K | -39.01%721.73K | -93.61%25K | -54.19%153K | 4.82%239K | 63.33%294K |
| Operating profit | 3.69%10.05M | -20.05%2.02M | -3.39%2.65M | 30.50%2.33M | 12.03%3.07M | 27.07%9.69M | 24.34%2.53M | 11.63%2.75M | 21.15%1.79M | 85.78%2.74M |
| Net non-operating interest income (expenses) | 58.73%-94.57K | -18.52%-32K | -120.00%-22K | 38.46%-24K | 84.97%-23K | 64.25%-229.16K | 83.54%-27K | 93.87%-10K | 76.22%-39K | -15.04%-153K |
| Non-operating interest expense | -58.73%94.57K | 18.52%32K | 120.00%22K | -38.46%24K | -84.97%23K | -64.25%229.16K | -83.54%27K | -93.87%10K | -76.22%39K | 15.04%153K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 42.98%57.91K | 53.66%63K | 123.17%40.5K | 41K | ||||||
| Less:Write off | -42.98%-57.91K | -53.66%-63K | ---- | ---- | ---- | -123.17%-40.5K | ---41K | ---- | ---- | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 5.37%10.01M | -19.27%2.05M | -3.84%2.63M | 32.04%2.31M | 17.75%3.05M | 39.53%9.5M | 35.99%2.54M | 19.12%2.74M | 33.33%1.75M | 92.78%2.59M |
| Income tax | 18.31%2.74M | -11.86%572K | -2.60%636K | 31.38%561K | 18.86%731K | 41.31%2.31M | 56.39%649K | 19.16%653K | 59.33%427K | 80.88%615K |
| Net income | 1.19%7.27M | -21.81%1.48M | -4.23%1.99M | 32.25%1.75M | 17.41%2.32M | 38.96%7.18M | 30.17%1.89M | 19.11%2.08M | 26.65%1.32M | 96.81%1.98M |
| Net income continuous operations | 1.19%7.27M | -21.81%1.48M | -4.23%1.99M | 32.25%1.75M | 17.41%2.32M | 38.96%7.18M | 30.17%1.89M | 19.11%2.08M | 26.65%1.32M | 96.81%1.98M |
| Noncontrolling interests | 119.47%823.69K | 580.95%143K | -37.05%141K | 348.65%332K | 257.81%229K | 160.84%375.31K | -51.16%21K | 229.41%224K | 184.62%74K | 2,033.33%64K |
| Net income attributable to the company | -5.32%6.45M | -28.56%1.34M | -0.27%1.85M | 13.47%1.42M | 9.36%2.09M | 35.47%6.81M | 32.65%1.87M | 10.60%1.86M | 22.62%1.25M | 91.01%1.91M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -5.32%6.45M | -28.56%1.34M | -0.27%1.85M | 13.47%1.42M | 9.36%2.09M | 35.47%6.81M | 32.65%1.87M | 10.60%1.86M | 22.62%1.25M | 91.01%1.91M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -5.43%0.0331 | -28.13%0.0069 | 0.00%0.0095 | 14.06%0.0073 | 9.18%0.0107 | 35.66%0.035 | 31.51%0.0096 | 10.47%0.0095 | 23.08%0.0064 | 92.16%0.0098 |
| Diluted earnings per share | -5.43%0.0331 | -28.13%0.0069 | 0.00%0.0095 | 14.06%0.0073 | 9.18%0.0107 | 35.66%0.035 | 31.51%0.0096 | 10.47%0.0095 | 23.08%0.0064 | 92.16%0.0098 |
| Dividend per share | -37.50%0.0125 | -33.33%0.005 | 0 | 0 | 50.00%0.0075 | 166.67%0.02 | 0.00%0.0075 | 0 | 0.0075 | 0.005 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.